title: New male contraceptive entering clinical trials worldwide.
mesh_terms: D000569:Americas; D001208:Asia; D001315:Australia; D001695:Biology; D002986:Clinical Trials as Topic; D003267:Contraception; D003270:Contraceptive Agents; D003272:Contraceptive Agents, Male; D019049:Developed Countries; D003906:Developing Countries; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D007390:International Agencies; D009656:North America; D009938:Organizations; D010139:Pacific Islands; D010827:Physiology; D010902:Pituitary Gland; D012106:Research; D013092:Spermatogenesis-Blocking Agents; D014480:United Nations; D014481:United States; D014861:Washington; D014944:World Health Organization
chemical_list: D003270:Contraceptive Agents; D003272:Contraceptive Agents, Male; D013092:Spermatogenesis-Blocking Agents
keywords: Americas; Asia; Australia; Biology; Clinical Research; Clinical Trials; Contraception; Contraceptive Agents, Male--pharmacodynamics; Contraceptive Agents, Male--side effects; Contraceptive Agents--pharmacodynamics; Contraceptive Agents--side effects; Developed Countries; Developing Countries; Endocrine System; Europe; Family Planning; International Agencies; Male Contraception; North America; Northern America; Oceania; Organizations; Physiology; Pituitary Gland; Research Methodology; Spermatogenesis Blocking Agents--pharmacodynamics; Spermatogenesis Blocking Agents--side effects; Un; United States; Washington; Who